Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan

Oral Diseases

Volumn 18, Issue 3, 2012, Pages 307-314

  Liu, C M ^a,b   Yeh, C J ^a   Yu, C C ^a,b   Chou, M Y ^a,b   Lin, C H ^c   Wei, L H ^d   Lin, C W ^a   Yang, S F ^a,b   Chien, M H ^c,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

IL 8; Oral cancer; Polymorphism

Indexed keywords

INTERLEUKIN 8;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; TAIWAN;

3' UNTRANSLATED REGIONS; ADENINE; ARECA; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOSINE; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-8; INTRONS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SMOKING; THYMINE;

EID: 84857795800     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01882.x     Document Type: Article

References (66)

1. Benoy IH, Salgado R, Van Dam P et al (2004). Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10: 7157-7162.
2. Biolchini F, Pollastri G, Figurelli S, Chiarini L (2005). Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatol 54: 405-414.
3. Boldrini L, Gisfredi S, Ursino S et al (2005). Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Lung Cancer 50: 309-317.
4. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000). Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12: 78-85.
5. Cacev T, Radosevic S, Krizanac S, Kapitanovic S (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29: 1572-1580.
6. Campa D, Hung RJ, Mates D et al (2005). Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2457-2458.
7. Chang KW, Lee TC, Yeh WI et al (2004). Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 91: 1551-1555.
8. Chen MK, Chiou HL, Su SC et al (2009). The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 45: e222-e226.
9. Chen MK, Tsai HT, Chung TT et al (2010). Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer. Head Neck 32: 1079-1087.
10. Cheng YA, Shiue LF, Yu HS, Hsieh TY, Tsai CC (2000). Interleukin-8 secretion by cultured oral epidermoid carcinoma cells induced with nicotine and/or arecoline treatments. Kaohsiung J Med Sci 16: 126-133.
11. Chien MH, Yeh CB, Li YC et al (2011). Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol 104: 798-803.
12. Chung TT, Pan MS, Kuo CL et al (2011). Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan. Carcinogenesis 32: 1063-1068.
13. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010). AJCC cancer staging manual, 7th edn. Springer: New York, NY, pp. 111-122.
14. Gao LB, Pan XM, Jia J et al (2010). IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer 46: 1333-1343.
15. Gu WL, Yang JJ (2011). [Expression and clinical significance of serum interleukin-8 level in patients with oral squamous cell carcinoma]. Shanghai Kou Qiang Yi Xue 20: 78-81.
16. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 15: 1126-1131.
17. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
18. Howell WM, Turner SJ, Theaker JM, Bateman AC (2003). Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30: 409-414.
19. Huang S, Mills L, Mian B et al (2002). Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161: 125-134.
20. Huang SF, Chen IH, Liao CT, Wang HM, Liou SH, Hsieh LL (2009). Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing. Oral Oncol 45: 16-22.
21. Hull J, Thomson A, Kwiatkowski D (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55: 1023-1027.
22. Hull J, Ackerman H, Isles K et al (2001). Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 69: 413-419.
23. Kamangar F, Abnet CC, Hutchinson AA et al (2006). Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17: 117-125.
24. Kim SJ, Uehara H, Karashima T, McCarty M, Shih N, Fidler IJ (2001). Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 3: 33-42.
25. van der Kuyl AC, Polstra AM, Weverling GJ, Zorgdrager F, van den Burg R, Cornelissen M (2004). An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case-control study. AIDS 18: 1206-1208.
26. Lai KC, Lee TC (2006). Genetic damage in cultured human keratinocytes stressed by long-term exposure to areca nut extracts. Mutat Res 599: 66-75.
27. Lee WP, Tai DI, Lan KH et al (2005). The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11: 6431-6441.
28. Leibovici D, Grossman HB, Dinney CP et al (2005). Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol 23: 5746-5756.
29. Lerebours F, Vacher S, Andrieu C et al (2008). NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8: 41.
30. Li A, Varney ML, Singh RK (2001). Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7: 3298-3304.
31. Lin MH, Wang CJ, Huang HP, Chou MY, Chou FP (2004). The tumorigenic characteristics of lime-piper betel quid-transformed JB6 cells. Arch Toxicol 78: 167-173.
32. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS (2006). Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243: 47-54.
33. Lin PY, Yu CH, Wang JT et al (2008). Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 37: 18-25.
34. Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL (1998). Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 18: 77-81.
35. Nagaraj NS, Beckers S, Mensah JK, Waigel S, Vigneswaran N, Zacharias W (2006). Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett 165: 182-194.
36. Nagler RM (2009). Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 45: 1006-1010.
37. Ohyauchi M, Imatani A, Yonechi M et al (2005). The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54: 330-335.
38. Orr N, Chanock S (2008). Common genetic variation and human disease. Adv Genet 62: 1-32.
39. Poli V (1998). The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273: 29279-29282.
40. Ren Y, Poon RT, Tsui HT et al (2003). Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9: 5996-6001.
41. Savage SA, Hou L, Lissowska J et al (2006). Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 15: 589-591.
42. Sharma R, Ahuja M, Panda NK, Khullar M (2010). Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in North Indians. DNA Cell Biol 29: 441-448.
43. Shastry BS (2002). SNP alleles in human disease and evolution. J Hum Genet 47: 561-566.
44. Sheryka E, Wheeler MA, Hausladen DA, Weiss RM (2003). Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma. Urology 62: 162-166.
45. Shi Q, Abbruzzese JL, Huang S, Fidler IJ, Xiong Q, Xie K (1999). Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5: 3711-3721.
46. Shimizu Y, Kondo S, Shirai A, Furukawa M, Yoshizaki T (2008). A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35: 381-389.
47. Slaton JW, Inoue K, Perrotte P et al (2001). Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol 158: 735-743.
48. Smith KC, Bateman AC, Fussell HM, Howell WM (2004). Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 31: 167-173.
49. Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L (2006). Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 67: 13-21.
50. Song C, Xing D, Tan W, Wei Q, Lin D (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275.
51. Taguchi A, Ohmiya N, Shirai K et al (2005). Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14: 2487-2493.
52. Teng YH, Liu TH, Tseng HC et al (2009). Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head Neck 31: 1282-1288.
53. Thorgeirsson SS, Grisham JW (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346.
54. Vairaktaris E, Yapijakis C, Wiltfang J et al (2005). Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res 25: 2561-2565.
55. Vairaktaris E, Yapijakis C, Derka S et al (2006a). Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. Eur J Surg Oncol 32: 455-457.
56. Vairaktaris E, Yapijakis C, Serefoglou Z et al (2006b). Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42: 888-892.
57. Vairaktaris E, Yapijakis C, Serefoglou Z et al (2007). The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33: 504-507.
58. Vairaktaris E, Yapijakis C, Serefoglou Z et al (2008). The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res 28: 309-314.
59. Venkatakrishnan G, Salgia R, Groopman JE (2000). Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275: 6868-6875.
60. Vogel U, Christensen J, Wallin H, Friis S, Nexo BA, Tjonneland A (2007). Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617: 138-146.
61. Wang Y, Yang J, Gao Y et al (2005). Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell Mol Immunol 2: 365-372.
62. Wei YS, Lan Y, Tang RG et al (2007). Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 125: 309-317.
63. Yang HP, Woodson K, Taylor PR et al (2006). Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev 15: 249-253.
64. Yen CY, Liu SY, Chen CH et al (2008). Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37: 271-277.
65. Zabaleta J, Su LJ, Lin HY et al (2009). Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30: 1358-1362.
66. Zhang XY, Chan WY, Whitney BM et al (2002). Changes of interleukin expression correlate with Helicobacter pylori infection and lymph node metastases in gastric carcinoma. Diagn Mol Pathol 11: 135-139.